Status:

COMPLETED

A RESearch on the PrEvalence and the Diagnosis of COPD and Its Tobacco-related Etiology

Lead Sponsor:

Université Catholique de Louvain

Collaborating Sponsors:

Northern State Medical University

Conditions:

Chronic Obstructive Pulmonary Disease

Eligibility:

All Genders

35-70 years

Brief Summary

The aim of the RESPECT study is to gain a better understanding of the prevalence, pathogenesis and symptoms of early chronic obstructive pulmonary disease (COPD). This study seeks to address the follo...

Detailed Description

Two northwestern of Russian Federation (RF) cities (St.Petersburg and Arkhangelsk) were selected for the RESPECT study. Fifteen primary care centers were invited to participate in this study. Fifteen...

Eligibility Criteria

Inclusion

  • •written consent to participate
  • Inclusion criteria for the cohort component:
  • •100 newly detected persons with FEV1/FVC less than 0.7 or less than LLN before and after reversibility test.
  • Inclusion criteria for the case-control component:
  • Both for cases and controls:
  • •A smoking history of more than 10 pack-years based on pack/year criteria
  • Test cases will include 100 participants that meet the following criteria:
  • Smokers aged 35-70 years with a smoking history of \>10 pack-years.
  • Completely irreversible airway obstruction based on the following criteria: FEV1/FVC \< 0.70 according to GOLD criteria or FEV1/FVC \< LLN.
  • Test controls will include 100 participants based on the following criteria:
  • •Smokers aged 35-70 years with a smoking history of \>10 pack/years and without COPD according to GOLD or LLN criteria, without asthma (absence of symptoms), with a negative history of allergies, and free from use of bronchodilators.

Exclusion

  • COPD exacerbation during last 3 months
  • Patient did not sign an informed consent
  • Patient refuses to participate

Key Trial Info

Start Date :

June 1 2012

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 1 2019

Estimated Enrollment :

3133 Patients enrolled

Trial Details

Trial ID

NCT02307799

Start Date

June 1 2012

End Date

January 1 2019

Last Update

January 23 2019

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

City Policlinic Number 2

Arkhangelsk, Russia, 163009

2

Family medicine center

Saint Petersburg, Russia, 194291

A RESearch on the PrEvalence and the Diagnosis of COPD and Its Tobacco-related Etiology | DecenTrialz